Genelux Corporation ( GNLX) - Key Metrics
GNLX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.21 | -$0.14 | -$0.18 |
| 2026Q1 | $0 | -$0.22 | -$0.19 | -$0.21 |
| 2025Q4 | $0 | -$0.25 | -$0.17 | -$0.18 |
| 2025Q3 | $0 | -$0.21 | -$0.17 | -$0.19 |
| 2025Q2 | $0 | -$0.20 | -$0.19 | -$0.19 |
GNLX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.58 |
| 2026Q1 | 0% | -2.75 |
| 2025Q4 | 0% | -4.36 |
| 2025Q3 | 0% | -5 |
| 2025Q2 | 0% | -3.59 |
GNLX
Price: $2.72
52 week price:
Earnings Per Share: -0.86 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 121.3 million